Understanding the value of meningococcal vaccination for adolescents and young adults in the United States: insights from a steady-state modelling approach
The two doses of MenACWY that are currently recommended play a crucial role in reducing the burden of IMD and the first dose contributes significantly (≥ 90%) to this reduction. It is essential to take this finding into account when considering any updates to the adolescent meningococcal vaccination schedule in the United States.
Authors
- Ayşegül Doğu
- E. Clay (ORCID: https://orcid.org/0000-0003-4398-1999)
- Edith Langevin
- Katherine Galarza (ORCID: https://orcid.org/0000-0003-4950-9425)
- Olivier Cristeau (ORCID: https://orcid.org/0000-0001-7434-4349)
- Corwin A. Robertson (ORCID: https://orcid.org/0000-0002-3462-7368)
- Jian Wu (ORCID: https://orcid.org/0000-0002-3394-1507)
- Taeksoo Shin (ORCID: https://orcid.org/0000-0003-2703-4705)
Institutions
- York University (CA)
- Sanofi (France) (FR)
- Dubai Medical College (AE)
- Swift Engineering (United States) (US)
Publication Details
- Journal
- BMC Public Health
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1186/s12889-025-21953-8
- Citations
- 2
- Primary Topic
- Bacterial Infections and Vaccines
- Type
- article
- Field-Weighted Citation Impact
- 2.37
Funders
- Sanofi